latest7 years ago
FDA approves first treatment for Erdheim-Chester Disease, a rare blood cancer
The U.S. Food and Drug Administration has expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a...
